semaglutide news october 16 2025 Good news, trypanophobics (people afraid of needles). Novo Nordisk now offers a weight-loss drug that's a little easier to swallow. The drugmaker announced today it's launching its daily Wegovy pill in Use of semaglutide linked to
Description
doi:10.1111/dom.14725.
In the Step 1 trial (note: funded by Novo-Nordisk) of 1,961 individuals, the average weight loss at 68 weeks was 14.9% at the maximum dose of 2.4 mg weekly, equating to 15.3 kg (33.6 lbs) lost compared to 2.6 kg (5.7 lbs) in the placebo group
An injection is given once weekly Rybelsus- tablet given once daily Exenatide: It is sold as Byetta is injected twice daily Bydureon injected once a week Liraglutide: the available brands are Victoza is used to treat Type 2 DM Saxenda used to manage chronic weight management Dulaglutide: It is marketed as Trulicity
The safety of our programs is a top priority
Tirzepatide and semaglutide are available now
& Zwahlen, M
